Itay Lotan

1.7k total citations
54 papers, 858 citations indexed

About

Itay Lotan is a scholar working on Neurology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Itay Lotan has authored 54 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 29 papers in Pathology and Forensic Medicine and 13 papers in Rheumatology. Recurrent topics in Itay Lotan's work include Peripheral Neuropathies and Disorders (31 papers), Multiple Sclerosis Research Studies (28 papers) and Systemic Lupus Erythematosus Research (10 papers). Itay Lotan is often cited by papers focused on Peripheral Neuropathies and Disorders (31 papers), Multiple Sclerosis Research Studies (28 papers) and Systemic Lupus Erythematosus Research (10 papers). Itay Lotan collaborates with scholars based in Israel, United States and Germany. Itay Lotan's co-authors include Mark A. Hellmann, Israel Steiner, Hadas Stiebel‐Kalish, Michael Levy, Ruth Djaldetti, T. A. Treves, Omer Bialer, Michael Bach, Friedemann Paul and Adi Wilf‐Yarkoni and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Itay Lotan

51 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itay Lotan Israel 15 562 462 163 109 102 54 858
Michael Karenfort Germany 13 430 0.8× 493 1.1× 162 1.0× 7 0.1× 82 0.8× 32 828
Barbara Willekens Belgium 13 140 0.2× 186 0.4× 38 0.2× 39 0.4× 46 0.5× 49 557
Yael Stern Israel 11 258 0.5× 526 1.1× 67 0.4× 11 0.1× 25 0.2× 15 679
Mehri Salari Iran 15 318 0.6× 219 0.5× 39 0.2× 6 0.1× 71 0.7× 92 662
Lawrence N. Marinucci United States 7 355 0.6× 785 1.7× 83 0.5× 47 0.4× 89 0.9× 8 1.0k
C J Mumford United Kingdom 11 154 0.3× 367 0.8× 103 0.6× 7 0.1× 51 0.5× 25 798
Saurabh Kataria United States 13 325 0.6× 91 0.2× 57 0.3× 9 0.1× 29 0.3× 50 565
Evanthia Bernitsas United States 15 243 0.4× 339 0.7× 57 0.3× 5 0.0× 28 0.3× 59 671
A. P. Batocchi Italy 16 460 0.8× 166 0.4× 34 0.2× 16 0.1× 96 0.9× 24 792
Z Lević Serbia 14 154 0.3× 339 0.7× 145 0.9× 11 0.1× 28 0.3× 42 576

Countries citing papers authored by Itay Lotan

Since Specialization
Citations

This map shows the geographic impact of Itay Lotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itay Lotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itay Lotan more than expected).

Fields of papers citing papers by Itay Lotan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itay Lotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itay Lotan. The network helps show where Itay Lotan may publish in the future.

Co-authorship network of co-authors of Itay Lotan

This figure shows the co-authorship network connecting the top 25 collaborators of Itay Lotan. A scholar is included among the top collaborators of Itay Lotan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itay Lotan. Itay Lotan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilodeau, Philippe‐Antoine, Anastasia Vishnevetsky, Itay Lotan, et al.. (2024). Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease. Multiple Sclerosis Journal. 30(3). 357–368. 13 indexed citations
2.
Lotan, Itay, et al.. (2023). Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD). Annals of Clinical and Translational Neurology. 10(4). 664–667. 3 indexed citations
3.
Lotan, Itay, Shuhei Nishiyama, Amy E. Wright, Jin Myoung Seok, & Michael Levy. (2023). Electrophysiological and Histological Correlations of Optic Neuritis in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis. Neuroscience. 524. 89–93.
4.
Lotan, Itay, Thibo Billiet, Annemie Ribbens, et al.. (2022). Volumetric brain changes in MOGAD: A cross-sectional and longitudinal comparative analysis. Multiple Sclerosis and Related Disorders. 69. 104436–104436. 6 indexed citations
5.
Lotan, Itay, et al.. (2022). Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis. Neuromuscular Disorders. 32(3). 230–235. 11 indexed citations
6.
Lotan, Itay, et al.. (2022). COVID-19 and the risk of CNS demyelinating diseases: A systematic review. Frontiers in Neurology. 13. 970383–970383. 14 indexed citations
7.
Wilf‐Yarkoni, Adi, Itay Lotan, Israel Steiner, & Mark A. Hellmann. (2021). Chronic low-dose intravenous immunoglobulins as steroid-sparing therapy in myasthenia gravis. Journal of Neurology. 268(10). 3871–3877. 8 indexed citations
8.
Kister, Ilya, et al.. (2020). CSF plasmablasts differentiate MS from other neurologic disorders. Multiple Sclerosis and Related Disorders. 48. 102719–102719. 2 indexed citations
9.
Lotan, Itay, Tamar Bacon, Ilya Kister, & Michael Levy. (2020). Paroxysmal symptoms in neuromyelitis optica spectrum disorder: Results from an online patient survey. Multiple Sclerosis and Related Disorders. 46. 102578–102578. 5 indexed citations
10.
11.
Lotan, Itay, Girish Fatterpekar, Maksim Shapiro, et al.. (2020). Progressive myelopathy associated with spinal epidural lipomatosis in three non-obese patients with type 1 diabetes mellitus. Journal of the Neurological Sciences. 411. 116688–116688. 6 indexed citations
12.
Stiebel‐Kalish, Hadas, Mark A. Hellmann, Michael Mimouni, et al.. (2019). Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?. Neurology Neuroimmunology & Neuroinflammation. 6(4). e572–e572. 133 indexed citations
13.
Lotan, Itay, et al.. (2019). Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders. 39. 101920–101920. 39 indexed citations
14.
Lotan, Itay, Mark A. Hellmann, Felix Benninger, Hadas Stiebel‐Kalish, & Israel Steiner. (2018). Recurrent optic neuritis – Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease. Journal of Neuroimmunology. 324. 115–118. 9 indexed citations
15.
Lotan, Itay, et al.. (2016). Psychiatric side effects of acute high-dose corticosteroid therapy in neurological conditions. International Clinical Psychopharmacology. 31(4). 224–231. 10 indexed citations
16.
Lotan, Itay, et al.. (2015). Atypical case of Morvan’s syndrome. Journal of Clinical Neuroscience. 25. 132–134. 5 indexed citations
17.
Lev, Nirit, Yael Barhum, Itay Lotan, Israel Steiner, & Daniel Offen. (2015). DJ-1 Knockout Augments Disease Severity and Shortens Survival in a Mouse Model of ALS. PLoS ONE. 10(3). e0117190–e0117190. 29 indexed citations
18.
Hellmann, Mark A., et al.. (2014). Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy. Journal of the Neurological Sciences. 344(1-2). 193–197. 26 indexed citations
19.
Hellmann, Mark A., et al.. (2013). Maintenance IVIg therapy in myasthenia gravis does not affect disease activity. Journal of the Neurological Sciences. 338(1-2). 39–42. 27 indexed citations
20.
Lotan, Itay, et al.. (2011). Primary brain T-cell lymphoma in an HTLV-1 serologically positive male. Journal of the Neurological Sciences. 314(1-2). 163–165. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Karenfort Breakdown of academic impact, for papers by Barbara Willekens Breakdown of academic impact, for papers by Yael Stern Breakdown of academic impact, for papers by Mehri Salari Breakdown of academic impact, for papers by Lawrence N. Marinucci Breakdown of academic impact, for papers by C J Mumford Breakdown of academic impact, for papers by Saurabh Kataria Breakdown of academic impact, for papers by Evanthia Bernitsas Breakdown of academic impact, for papers by A. P. Batocchi Breakdown of academic impact, for papers by Z Lević
Rankless by CCL
2026